1. Measurement of rivaroxaban concentrations demonstrates lack of clinical utility of a PT, dPT and APTT test in estimating levels. (2nd May 2018) Authors: Thom, I.; Cameron, G.; Robertson, D.; Watson, H. G. Journal: International journal of laboratory hematology Issue: Volume 40:Number 4(2018:Aug.) Page Start: 493 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP0021 A phase 2 study of multiple subcutaneous doses of LY2439821, an anti-IL-17 monoclonal antibody, in patients with rheumatoid arthritis in two populations: Naïve to biologic therapy or inadequate responders to tumor necrosis factor alpha inhibitors. (23rd January 2014) Authors: Genovese, M.; Greenwald, M.; Cho, C.-S.; Berman, A.; Jin, L.; Cameron, G.; Wang, L.; Xie, L.; Braun, D.; Berclaz, P.-Y.; Banerjee, S. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗